CerebroFlo™ EVD Catheter for Intraventricular Hemorrhage

Palo Alto (17 mi)

Overseen byRamesh Grandhi, MD

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: N/A

Recruiting

Sponsor: Integra LifeSciences Corporation

No Placebo Group

Trial Summary

What is the purpose of this trial?The primary goal of this study is to assess the occurrence of flushing interventions to address occlusions during the treatment of interventricular hemorrhage (spontaneous primary IVH or secondary IVH due to ruptured aneurysm).

Eligibility Criteria

This study is for adults over 18 who need an EVD Catheter for intraventricular hemorrhage treatment and can legally consent. It's not for those with uncorrectable bleeding disorders, catheter-related bleeding, scalp infections, pregnancy, or if the catheter was placed directly into a hematoma.

Inclusion Criteria

I am 18 years old or older.

I have had a CerebroFlo EVD Catheter placed after a brain hemorrhage without any issues.

Exclusion Criteria

I have a condition that causes abnormal bleeding.

I currently have a scalp infection.

I have a bleeding disorder that can't be corrected, caused by blood thinners.

Treatment Details

The trial tests the CerebroFlo™ EVD Catheter's effectiveness in preventing blockages during treatment of brain bleeds due to hemorrhage. The main focus is on how often flushing interventions are needed to clear occlusions.

1Treatment groups

Experimental Treatment

Group I: Intraventricular Hemorrhage SubjectsExperimental Treatment1 Intervention

Intervention: Cerebrospinal Fluid (CSF) reduction Extra Ventricular Drainage (EVD) catheters will be used for cerebrospinal fluid drainage